Objective: To study the clinical effect and safety of the the bleeding after cesarean section in high-risk pregnant women. Methods: 117 high-risk pregnant women undergoing cesarean section were the subject of this exp...Objective: To study the clinical effect and safety of the the bleeding after cesarean section in high-risk pregnant women. Methods: 117 high-risk pregnant women undergoing cesarean section were the subject of this experimental study, starting from October 2020 and ending in October 2021. The study of 117 patients according to the patients receiving treatment will be divided into C, D, E three groups, each group of patients have 39 cases, the given in group C patients carprostamine combined with oxytocin therapy, give group D patients carprostamine plug with hystercin therapy, group E is a single oxytocin treatment. Results: Comparison of intraoperative bleeding, 2 hours after, and 2-24 hours in the three groups, In Group C, For the three groups, p <0.05, However, the comparison between the D and E groups was not significantly different and different, p>0.05;in addition, The rates of blood transfusion, postpartum bleeding and assisted hemostasis interventions in the three groups were also the lowest in group C, By contrast: p <0.05, In addition, the comparison between the D and E groups was not significantly different, p>0.05;besides, The comparison between groups C, D, and E was not significantly different in the incidence of adverse reactions such as fever, diarrhea, elevated blood pressure, vomiting, and nausea, P>0.05. The clinical efficacy of group C was higher than that of group D and E (P <0.05), and there was no difference in the clinical efficacy between group D and E (P> 0.05). Compared with group D and E, group C had shorter hemostasis duration and longer contractions in group C (P <0.05), and no difference between the above indicators between group D and E (P> 0.05). Before the operation three groups of each coagulation index, hematocrit, please give you, hemoglobin levels, red blood cell technology is not significantly different, p> 0.05, however, after the three groups of surgery, it is clear that the group C patients index is better than group D and E patients, the three groups of p <0.05, group D, E each coagulation index is no difference (P> 0.05). Conclusion: The treatment of carprosterambutriol combined with oxytocin in high-risk pregnant women undergoing cesarean section can not only reduce the incidence of postpartum bleeding and improve the clinical effect, but also actively improve the coagulation function index and improve the hemoglobin level, red blood cell count and hematocrit.展开更多
文摘Objective: To study the clinical effect and safety of the the bleeding after cesarean section in high-risk pregnant women. Methods: 117 high-risk pregnant women undergoing cesarean section were the subject of this experimental study, starting from October 2020 and ending in October 2021. The study of 117 patients according to the patients receiving treatment will be divided into C, D, E three groups, each group of patients have 39 cases, the given in group C patients carprostamine combined with oxytocin therapy, give group D patients carprostamine plug with hystercin therapy, group E is a single oxytocin treatment. Results: Comparison of intraoperative bleeding, 2 hours after, and 2-24 hours in the three groups, In Group C, For the three groups, p <0.05, However, the comparison between the D and E groups was not significantly different and different, p>0.05;in addition, The rates of blood transfusion, postpartum bleeding and assisted hemostasis interventions in the three groups were also the lowest in group C, By contrast: p <0.05, In addition, the comparison between the D and E groups was not significantly different, p>0.05;besides, The comparison between groups C, D, and E was not significantly different in the incidence of adverse reactions such as fever, diarrhea, elevated blood pressure, vomiting, and nausea, P>0.05. The clinical efficacy of group C was higher than that of group D and E (P <0.05), and there was no difference in the clinical efficacy between group D and E (P> 0.05). Compared with group D and E, group C had shorter hemostasis duration and longer contractions in group C (P <0.05), and no difference between the above indicators between group D and E (P> 0.05). Before the operation three groups of each coagulation index, hematocrit, please give you, hemoglobin levels, red blood cell technology is not significantly different, p> 0.05, however, after the three groups of surgery, it is clear that the group C patients index is better than group D and E patients, the three groups of p <0.05, group D, E each coagulation index is no difference (P> 0.05). Conclusion: The treatment of carprosterambutriol combined with oxytocin in high-risk pregnant women undergoing cesarean section can not only reduce the incidence of postpartum bleeding and improve the clinical effect, but also actively improve the coagulation function index and improve the hemoglobin level, red blood cell count and hematocrit.
